Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, Level 5, Clinical Sciences Building, Newcastle Mater Hospital, Edith Street, Waratah, Newcastle, New South Wales, Australia, 2298.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.94). 01/2010; DOI: 10.1002/14651858.CD002042.pub2
Source: PubMed

ABSTRACT Most clinical practice guidelines recommend restrictive red cell transfusion practices, with the goal of minimising exposure to allogeneic blood (from an unrelated donor). The purpose of this review is to compare clinical outcomes in patients randomised to restrictive versus liberal transfusion thresholds (triggers).
To examine the evidence for the effect of transfusion thresholds on the use of allogeneic and/or autologous blood, and the evidence for any effect on clinical outcomes.
Trials were identified by: computer searches of the Cochrane Central Register of Controlled Trials (the Cochrane Library Issue 3, 2009), OVID MEDLINE (1966 to August 2009), Current Contents (1993 to November 2004), and the Web of Science (2004 to August 2009). References in identified trials and review articles were checked and experts contacted to identify any additional trials.
Controlled trials in which patients were randomised to an intervention group or to a control group. Trials were included where intervention groups were assigned on the basis of a clear transfusion 'trigger', described as a haemoglobin (Hb) or haematocrit (Hct) level below which an RBC transfusion was to be administered.
Relative risks of requiring allogeneic blood transfusion, transfused blood volumes and other clinical outcomes were pooled across trials, using a random effects model. The risk of bias was assessed.
Seventeen trials involving a total of 3746 patients were identified. Restrictive transfusion strategies reduced the risk of receiving a red blood cell (RBC) transfusion by a relative 37% (RR=0.63; 95% CI 0.54 to 0.74). This equates to an average absolute risk reduction (ARR) of 33% (95% CI 21% to 45%). The volume of RBCs transfused was reduced on average by 0.75 units (95% CI 0.20 to 1.30 units). However, heterogeneity between trials was statistically significant (P<0.001; I²≥74%) for these outcomes. Restrictive transfusion strategies did not appear to impact on the rate of adverse events compared to liberal transfusion strategies (i.e. mortality, cardiac events, myocardial infarction, stroke, pneumonia and thromboembolism). Restrictive transfusion strategies were associated with a statistically significant reduction in the rates of infection (RR=0.76; 95% CI 0.60 to 0.97). The use of restrictive transfusion strategies did not reduce hospital or intensive care length of stay.
The existing evidence supports the use of restrictive transfusion triggers in patients who are free of serious cardiac disease. The effects of conservative transfusion triggers on functional status, morbidity and mortality, particularly in patients with cardiac disease, need to be tested in further large clinical trials. In countries with inadequate screening of donor blood, the data may constitute a stronger basis for avoiding transfusion with allogeneic red cells.

Download full-text


Available from: David Henry, Dec 14, 2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Problem: A suspected high proportion of unnecessary blood transfusions occur in patients undergoing total joint replacement. Design: Prospective before and after study evaluating the impact of a one page flow chart aimed at reducing the use of blood transfusions. Setting: Orthopaedic tertiary care centre in Winterthur, Switzerland. 208 patients underwent primary total joint replacement of hips or knees during the control period (October 1998 to September 1999) and 217 during the intervention period (October 1999 to September 2000). Key measures for improvement: Proportion of patients receiving allogeneic blood transfusions. Strategies for change: A simple one page flow chart, which summarised graphically the perioperative decision pathways for anaemic patients, was placed in all charts of patients undergoing total joint replacement and handed out to medical staff from 4 October 1999 onwards. The implementation of the flow chart focused on its endorsement by chief physicians and the development of a sense of "ownership" among physicians and nurses. Effects of change: The proportion of patients receiving allogeneic blood decreased from 35.0% to 19.8% (absolute difference 215.2%, 95% confidence interval 223.3 to 27.0%). The percentage of patients donating and receiving autologous blood also decreased. This led to overall savings of about pound23 000 ($42 470; E34 441) (pound103.50 per patient undergoing total joint replacement). Differences became more pronounced after adjustment for confounding factors. Lessons learnt: Allogeneic blood transfusions in primary hip and knee replacement surgery may be reduced cost effectively by implementing a one page flow chart. Five key elements may have contributed: simplicity; wide distribution; no requirement for major changes; endorsement by local opinion leaders; and development of a sense of ownership. These elements may be used in other contexts to achieve sustained change of clinical practice.
    Quality and Safety in Health Care 12/2004; 13(6). DOI:10.1136/qhc.13.6.444 · 2.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: L’anémie est fréquente chez les patients pédiatriques en postopératoire de chirurgie cardiaque. Malgré le nombre important de patients transfusés, le taux d’hémoglobine (Hb) pour lequel les bénéfices surpassent les risques est inconnu chez ces patients. Récemment, Lacroix et al. ont démontré qu’une stratégie transfusionnelle restrictive n’était pas inférieure à une stratégie libérale en ce qui concerne le développement ou la progression du syndrome de défaillance multiviscérale (SDMV) et la mortalité chez les patients de soins intensifs pédiatriques (SIP).Devant le manque d’évidence, une analyse de sous-groupes des patients en postopératoire de chirurgie cardiaque de l’étude Transfusion Requirements in Pediatric Intensive Care (TRIPICU) a été réalisée. L’objectif de cette étude était de déterminer l’impact d’une stratégie transfusionnelle restrictive comparée à une stratégie libérale sur l’acquisition ou l’aggravation du syndrome de défaillance multiviscérale (SDMV) chez les enfants en postopératoire de chirurgie cardiaque. Cette étude n’a pas démontré de différences statistiquement, ni cliniquement significatives du nombre de patients ayant acquis ou aggravés un SDMV, ni des issues secondaires entre les stratégies transfusionnelles restrictive et libérale. L’analyse de sous-groupes permet de générer une hypothèse de recherche et les résultats devraient être confirmés par un essai randomisé contrôlé. Anemia is frequent in pediatric patients following cardiac surgery. Despite frequent transfusions, the optimal hemoglobin threshold where benefits surpass risks is still unknown for these patients. Recently, Lacroix et al. showed that a restrictive transfusion strategy was not inferior to a liberal strategy concerning the development or progression of multiple organ dysfunction syndrome (MODS) and mortality in pediatric intensive care patients. In the absence of evidence, the aim of this study was to determine the impact of a restrictive versus a liberal transfusion strategy on new or progressive multiple organ dysfunction syndrome (MODS) in children following cardiac surgery. We conducted a subgroup analysis of the postoperative cardiac surgery patients of the Transfusion Requirements in Pediatric Intensive Care Unit (TRIPICU) study. Our study showed no statistically and clinically significant differences in the number of patients who acquired or worsened MODS, nor secondary outcomes between a restrictive and a liberal transfusion strategy. This subgroup analysis generates a research hypothesis that should be confirmed by a randomized controlled trial.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Transfusion af saltvand, adenin, glukose og mannitol (SAGM) benyttes ofte i behandlingen af kritisk syge patienter, der er indlagt på en intensivafdeling [1]. I internationale studier er det vist, at 40-50% af alle intensivpatienter får SAGM-transfusioner, og mere end 90% af blodtransfusionerne administreres til ikkeblødende patienter med et gennemsnit på fem portioner SAGM pr. patient [2-4]. Forbruget af SAGM på danske intensivafdelinger er på samme niveau og er beskrevet i et nyere kohor-testudie. Niogtres ud af 132 (52%) patienter med septisk shock på seks intensivafdelinger i Østdanmark fik SAGM-transfusion inden for det første indlaeggel-sesdøgn [5]. Blodtransfusion har traditionelt vaeret opfattet som en virksom behandling til patienter med anaemi – isaer til patienter med kliniske tegn på nedsat vaevsoxy-genering. Ny viden om transfusion har sat fokus på im-munmodulerende egenskaber af blod og på lagringens virkninger på blodets iltbaerende egenskaber som mu-lig forklaring på de potentielt skadelige virkninger på kritisk syge recipienter. Derfor er diskus sionen om, hvorvidt den samlede virkning af blodtransfusion er gavnlig, hvilke haemoglobinniveauer der er optimale for ikkeblødende patienter, og praecis hvilke kritisk syge patienter der kan have gavn af SAGM, fortsat aktuel. Denne statusartikel beskriver virkninger og bivirkninger ved SAGM-transfusion til ikkeblødende kritisk syge patienter og diskuterer den aktuelle evi-dens og de aktuelle rekommandationer på området. PATOFYSIOLOGI Blod administreres for at øge haemoglobinkoncentra-tionen og dermed blodets iltbaerende kapacitet. Her-ved øges det globale ilttilbud (DO 2), men det er uvist, om det perifere ilttilbud øges som resultat heraf. Hos forskellige grupper af kritisk syge patienter, herunder patienter med septisk shock, er det vist, at DO 2 øges efter blodtransfusion, men at iltforbruget (VO 2) ikke nødvendigvis øges [6]. En mulig fortolkning af disse data er, at transfunderede erytrocytter ikke afgiver ilt så godt som genuine celler, og der er på denne bag-grund blevet stillet spørgsmålstegn ved den ønskede virkning af transfusion på vaevsiskaemi [7]. Storage lesion Hos den kritisk syge kan den i forvejen heterogene kapillaere perfusion som følge af perifer stase og shunt forvaerres efter blodtransfusion. Den mulige år-sag hertil er sammenfaldende med den potentielt manglende virkning af transfusion, nemlig kombina-tionen af aendret mikrocirkulation og kvalitative aen-dringer i blodet som følge af lagring. De biokemiske og morfologiske aendringer, der opstår i erytrocytten og dens medie, når den lagres ex vivo, kaldes samlet for storage lesion. Morfologisk sker der under lagrin-gen en korpuskular omdannelse af erytrocytten, hvil-ket samlet fører til, at lagrede erytrocytter har nedsat evne til at navigere i mikrocirkulationen og nedsat evne til at frigive oxygen til perifere vaev [8].
Show more